Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Novavax Company Profile (NASDAQ:NVAX)

Consensus Ratings for Novavax (NASDAQ:NVAX) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.70 (156.59% upside)

Analysts' Ratings History for Novavax (NASDAQ:NVAX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/11/2014Ladenburg ThalmannBoost Price TargetBuy$4.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
12/16/2013WedbushBoost Price TargetPositive$12.00ViewTweet This Rating  Share This Rating on StockTwits
11/18/2013FBR Capital MarketsReiterated RatingOutperform -> Positive$11.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR Capital MarketsInitiated CoverageOutperform$11.00ViewTweet This Rating  Share This Rating on StockTwits
9/25/2013MLV & Co.Boost Price TargetBuy$8.50 -> $9.50ViewTweet This Rating  Share This Rating on StockTwits
8/15/2013Lazard Capital MarketsBoost Price TargetPositive$4.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2013Piper JaffrayReiterated RatingOverweightViewTweet This Rating  Share This Rating on StockTwits
4/5/2013WedbushReiterated RatingOutperform$4.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013Burrill Institutional ResearchInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Brinson PatrickReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
3/5/2013WedbushLower Price TargetOutperform$6.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
12/5/2012Piper JaffrayReiterated RatingOverweight$3.00ViewTweet This Rating  Share This Rating on StockTwits
10/29/2012Brinson PatrickInitiated CoverageOutperform$3.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/24/2012 forward)